EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis

Emma L Ledger iD, Daniel J Smith, Jing Jie Teh iD, Michelle E Wood, Page E Whibley, Mark Morrison iD, Joanna B Goldberg, David W Reid, Timothy J Wells iD

The Journal of Infectious Diseases · 23.09.2024 · 230 (3) · e536-e547

DOI: 10.1093/infdis/jiae051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 05.03.2024. Verfasst von Emma L Ledger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, Common Good Prince Charles Hospital Foundation, Cystic Fibrosis Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pseudomonas aeruginosa is a multidrug-resistant pathogen causing recalcitrant pulmonary infections in people with cystic fibrosis (pwCF). Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been developed that partially correct the defective chloride channel driving disease. Despite the many clinical benefits, studies in adults have demonstrated that while P. aeruginosa sputum load decreases, chronic infection persists. Here, we investigate how P. aeruginosa in pwCF may change in the altered lung environment after CFTR modulation.

Methods

P. aeruginosa strains (n = 105) were isolated from the sputum of 11 chronically colonized pwCF at baseline and up to 21 months posttreatment with elexacaftor-tezacaftor-ivacaftor or tezacaftor-ivacaftor. Phenotypic characterization and comparative genomics were performed.

Results

Clonal lineages of P. aeruginosa persisted after therapy, with no evidence of displacement by alternative strains. We identified commonly mutated genes among patient isolates that may be positively selected for in the CFTR-modulated lung. However, classic chronic P. aeruginosa phenotypes such as mucoid morphology were sustained, and isolates remained just as resistant to clinically relevant antibiotics.

Conclusions

Despite the clinical benefits of CFTR modulators, clonal lineages of P. aeruginosa persist that may prove just as difficult to manage in the future, especially in pwCF with advanced lung disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPseudomonas aeruginosaPseudomonas InfectionsCystic Fibrosis Transmembrane Conductance RegulatorAminophenolsQuinolonesDrug CombinationsSputumHumansIndolesBenzodioxolesAdultFemalePyrazolesMaleAnti-Bacterial AgentsMutationPersistent InfectionPyridinesQuinolines

Stichwörter der Autor:innen

Pseudomonas aeruginosaCFTR modulatorsETIcystic fibrosiselexacaftor-tezacaftor-ivacaftor

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorAminophenolsQuinolonesDrug CombinationsIndolesBenzodioxolesCFTR protein, humanelexacaftor, ivacaftor, tezacaftor drug combinationPyrazolesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
  • Northside Clinical Unit, The University of Queensland, Brisbane, Australia.
  • Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Australia.
  • Australian Infectious Diseases Research Centre, Brisbane, Australia.
  • Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, USA.
  • QIMR Berghofer Medical Research Institute, Brisbane, Australia.

ORCID-Profile: Emma L Ledger, Jing Jie Teh, Mark Morrison, Timothy J Wells

Förderung

  • Cystic Fibrosis Foundation
  • Common Good Prince Charles Hospital Foundation
  • Cystic Fibrosis Australia

Zitieren

APA

Ledger, E. L., Smith, D. J., Teh, J. J., Wood, M. E., Whibley, P. E., Morrison, M., Goldberg, J. B., Reid, D. W., & Wells, T. J. (2024). Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis. The Journal of Infectious Diseases, 230(3), e536-e547. https://doi.org/10.1093/infdis/jiae051

Vancouver

Ledger EL, Smith DJ, Teh JJ, Wood ME, Whibley PE, Morrison M, et al. Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis. The Journal of Infectious Diseases. 2024;230(3):e536-e547. doi:10.1093/infdis/jiae051

BibTeX
@article{Ledger2024,
  author = {Ledger, Emma L and Smith, Daniel J and Teh, Jing Jie and Wood, Michelle E and Whibley, Page E and Morrison, Mark and Goldberg, Joanna B and Reid, David W and Wells, Timothy J},
  title = {Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {3},
  pages = {e536--e547},
  doi = {10.1093/infdis/jiae051}
}
Kostenlos starten →